Digital Pathology Market is Expected to Register a Revenue CAGR of 13.2% Till the Forecast Period 2030

The global Digital Pathology Market size is expected to reach USD 2,234.9 Million in 2030 and register a revenue CAGR of 13.2% over the forecast period, according to the latest report by Reports and Data. The increasing incidence of cancer and growing application of digital pathology in drug development and companion diagnostics are driving digital pathology market revenue growth.

Market growth is also likely to be aided by rapid technological advancements in digital pathology systems. Digital photography, computerization, robotic light microscopy, and numerous fiber optic connectivity are all helping to drive the industry forward. Whole Slide Imaging(WSI) is one such approach that has a number of advantages over light microscopes and is expected to create revenue opportunities in this market. The use of Artificial Intelligence (AI) in healthcare is increasing, with a growing emphasis on enhancing patient care quality by incorporating AI into many elements of health care, such as pathological diagnosis.

The global Digital Pathology market research report provides a brief overview inclusive of the competitive landscape and key developments in the market. It provides an extensive study analysis of the strategic alliances such as mergers and acquisitions, joint ventures, collaborations, product launches, brand promotions, corporate deals, and partnerships, among others. It also offers insights into the company overview, financial standing, business expansion plans, and revenue growth of each company. It also sheds light on product advancement, technological developments, and research and development activities.

Key Players:

Companies profiled in the global market report include Leica Biosystems Nussloch GmbH, Hamamatsu Photonics K.K., F. Hoffmann-La Roche Ltd., 3DHISTECH Ltd., Apollo Enterprise Imaging Corp., XIFIN, Inc., Huron Technologies International Inc., Visiopharm A/S, Aiforia Technologies, and Akoya Biosciences, Inc.